HIF1A antibody (70R-10570)

Affinity purified rabbit polyclonal HIF1A antibody

Synonyms Polyclonal HIF1A antibody, Anti-HIF1A antibody, HIF1-ALPHA antibody, HIFA-1, hypoxia-inducible factor 1, MOP1 antibody, HIF1 antibody, PASD8 antibody, HIFA 1 antibody, HIFA-1 antibody, HIF-1alpha antibody, HIFA 1, HIF1A, alpha subunit antibody
Cross Reactivity Human, Mouse, Rat, Bovine, Rabbit, Pig, Chicken, African Clawed Frog
Applications IHC, WB
Immunogen HIF1A antibody was raised in rabbit using the N terminal of HIF1A as the immunogen

Images

HIF1A Abundant Oxygen vs Hypoxia

When oxygen is abundant, HIF1A is rapidly degraded by a family of three hypoxia-inducible factor prolyl hydroxylase (EGLN; HIF-PH; PHD) enzymes: PHD1, PHD2 and PHD3 (I[a]). The enzymes increase HIF1A's affinity for a tumor-suppressor protein called von Hippel-Lindau (VHL) and target HIF1A to the proteasome for degradation (I[b]). During oxygen deprivation, or hypoxia, HIF1A avoids proteasome-mediated degradation and instead accumulates in the nucleus, where it forms a dimer with HIF1B (II[a]).

Specifications

Host Rabbit
Form & Buffer Lyophilized powder. Add 50 ul of distilled water. Final antibody concentration is 1 mg/ml in PBS buffer.
Concentration 1 mg/ml

Usage & Assay Information

Usage Recommendations WB: 0.2-1 ug/ml

Storage & Safety

Storage Store at 4 deg C, following reconstitution, aliquot and store at -20 deg C. Avoid repeated freeze-thaw cycles.

General Information

Product Use Purified Polyclonal HIF1A antibody specific for human HIF1A for use in Immunohistochemistry and Western blot
Biological Significance HIF1A is a master transcriptional regulator of the adaptive response to hypoxia. Under hypoxic conditions, activates the transcription of over 40 genes, including erythropoietin, glucose transporters, glycolytic enzymes, vascular endothelial growth factor, HILPDA, and other genes whose protein products increase oxygen delivery or facilitate metabolic adaptation to hypoxia. HIF1A plays an essential role in embryonic vascularization, tumor angiogenesis and pathophysiology of ischemic disease. Binds to core DNA sequence 5'-[AG]CGTG-3' within the hypoxia response element (HRE) of target gene promoters. Activation requires recruitment of transcriptional coactivators such as CREBPB and EP300. Activity is enhanced by interaction with both, NCOA1 or NCOA2. Interaction with redox regulatory protein APEX seems to activate CTAD and potentiates activation by NCOA1 and CREBBP. Involved in the axonal distribution and transport of mitochondria in neurons during hypoxia.
Expression HIF1A is up-regulated in peripheral T lymphocytes after T-cell receptor stimulation. Highest expression in peripheral blood leukocytes and thymus. HIF1A is located in the cytoplasm and nucleus. It is cytoplasmic in normoxia, nuclear translocation in response to hypoxia. Colocalizes with SUMO1 in the nucleus, under hypoxia. HIF1A is expressed in most tissues with highest levels in kidney and heart and is commonly overexpressed in the majority of common human cancers and their metastases.
Implications in Disease Overexpression of a natural antisense transcript (aHIF) of the HIF1A gene is associated with nonpapillary renal carcinomas.
Sequence Information HIF1A contains a bHLH domain at amino acids 17 – 70, contains a PAS 1 domain at amino acids 85 – 158, a PAS 2 domain at amino acids 228 – 298 and a PAC domain at amino acids 302 – 345.
Post-Translational Modifications HIF1A is hydroxylated on Pro-402 and Pro-564 in the oxygen-dependent degradation domain (ODD) by EGLN1/PHD1 and EGLN2/PHD2. EGLN3/PHD3 has also been shown to hydroxylate Pro-564. In normoxia, HIF1A is hydroxylated on Asn-803 by HIF1AN, thus abrogating interaction with CREBBP and EP300 and preventing transcriptional activation. Sumoylated: HIF1A is sumyolated with SUMO1 under hypoxia. Sumoylation is enhanced through interaction with RWDD3. Desumoylation by SENP1 leads to increased HIF1A stability and transriptional activity.
Database Links Entrez Gene: 3091 Human, Omim: 603348 Human, SwissProt: Q16665 Human, Unigene: 597216 Human

References
Add a Paper

Sorry, but there are no references currently for this product.

Reviews

You need to be logged in to write a review. Please login here

Sorry there are currently no reviews for this product

Images

  • HIF1A Abundant Oxygen vs Hypoxia | When oxygen is abundant, HIF1A is rapidly degraded by a family of three hypoxia-inducible factor prolyl hydroxylase (EGLN; HIF-PH; PHD) enzymes: PHD1, PHD2 and PHD3 (I[a]). The enzymes increase HIF1A's affinity for a tumor-suppressor protein called von Hippel-Lindau (VHL) and target HIF1A to the proteasome for degradation (I[b]). During oxygen deprivation, or hypoxia, HIF1A avoids proteasome-mediated degradation and instead accumulates in the nucleus, where it forms a dimer with HIF1B (II[a]).
  • Western blot analysis using HIF1A antibody (70R-10570) | Recommended Antibody Titration: 0.2-1 ug/ml
  • Immunohistochemical staining using HIF1A antibody (70R-10570) | Brain, cerebellum

Availability: In stock

Price: $345.00
Size: 50 ug
OR
Shipping
View Our Distributors